We investigated the mechanism of cytoskeletal protein degradation after 48 h of (A) both AICD transfection and the addition of Aβ (AD-inducing condition) or (B) both AICD transfection and Aβ treatment along with Grb2 overexpression (AD reversal condition). Here, GRB2 is linked to Alzheimer disease.